: A A

Archive | Clinical News Room

CNS Summit – October 8-11, 2015 Boca Raton, FL – Attended

Thursday, July 16, 2015

0 Comments

http://cnssummit.org/Default.aspx#  

Ireland Leads Obesity Epidemic in Europe, Others Close Behind

Thursday, May 7, 2015

0 Comments

May 06, 2015 PRAGUE, Czech Republic — Europe is facing an obesity crisis of gigantic proportions by 2030, according to the latest projections released by the World Health Organization (WHO) here at the 2015 European Congress on Obesity. The data highlight a serious problem for many countries: in Ireland, almost everyone — 90% of men […]

Seasonal Influenza Vaccine Only 23% Effective This Year

Friday, January 16, 2015

0 Comments

January 15, 2015 An early analysis of the 2014 to 2015 influenza season notes that two thirds of the circulating influenza A (H3N2) viruses differ from the H3N2 component of the 2014 to 2015 influenza vaccine. The 2014 to 2015 seasonal influenza vaccine is thus estimated to be only 23% effective in preventing medically attended, […]

Friend or Foe: The Great e-Cigarette Debate

Monday, December 29, 2014

0 Comments

December 22, 2014 AVENTURA, Florida ― e-Cigarettes ― are they a welcome addition to the smoking cessation armamentarium, or are they gateway devices to smoking with potentially serious hidden health costs? Dr Mary Brunette Here at the American Academy of Addiction Psychiatry (AAAP) 25th Annual Meeting, addiction experts weighed in on the devices during a […]

Anti-inflammatories May Help Ease Depression

Wednesday, November 5, 2014

0 Comments

October 21, 2014 Nonsteroidal anti-inflammatory drugs (NSAIDs) may help ease depressive symptoms, new research suggests. Results of a meta-analysis show that the adjunctive use of NSAIDs was associated with improved antidepressant treatment response without an increased risk for adverse effects. In particular, add-on treatment with celecoxib (Celebrex, GD Searle LLC) improved antidepressant effects, remission, and response. "Our analysis suggests that anti-inflammatory treatment, in particular celecoxib, decreases depressive symptoms without increased risks of adverse effects," the authors, led by Ole Kohler, MD, of Aarhus University Hospital, Risskov, Denmark, write. The study was published online October 15 in JAMA Psychiatry.

Heart Disease Risk: Low-Carb Diet Trumps Low-Fat Option

Thursday, September 4, 2014

0 Comments

September 4, 2014 A low-carbohydrate diet may be better than a low-fat diet for losing weight and reducing risks for cardiovascular disease (CVD), according to an article published in the September 2 issue of Annals of Internal Medicine. Lydia A. Bazzano, MD, PhD, MPH, from the Department of Epidemiology at Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, and colleagues conducted a randomized trial involving 148 adults who did not have diabetes or CVD. The researchers randomly assigned 75 participants to the low-carbohydrate group and 73 to the low-fat group, with 59 (79%) low-carbohydrate participants and 60 (82%) low-fat participants completing the 1-year study. The groups were well matched, with a median age of 47.8 years in the low-fat group and 45.8 years in the low-carbohydrate group and baseline body mass indexes of 35.6 and 35.2 kg/m2. The groups were predominately female (89% and 88%, respectively) but were racially mixed, with approximately equal numbers of blacks (36 and 40, respectively) and whites (33 and 34, respectively) in each group.

Marijuana Compound May Slow, Halt Alzheimer’s

Thursday, August 28, 2014

0 Comments

August 28, 2014 Extremely low levels of the compound in marijuana known as delta-9-tetrahydrocannabinol, or THC, may slow or halt the progression of Alzheimer’s disease, a recent study from neuroscientists at the University of South Florida shows. Findings from the experiments, using a cellular model of Alzheimer’s disease, were reported online in the Journal of Alzheimer’s Disease. Researchers from the USF Health Byrd Alzheimer’s Institute showed that extremely low doses of THC reduce the production of amyloid beta, found in a soluble form in most aging brains, and prevent abnormal accumulation of this protein— a process considered one of the pathological hallmarks evident early in the memory-robbing disease. These low concentrations of THC also selectively enhanced mitochondrial function, which is needed to help supply energy, transmit signals, and maintain a healthy brain.

TNF Inhibitors for RA: No Link to Breast Cancer

Tuesday, August 19, 2014

0 Comments

August 19, 2014 Patients who have had breast cancer and who start tumor necrosis factor inhibitor (TNFi) treatment for rheumatoid arthritis (RA) more than 5 years after the cancer diagnosis may not be more subject to breast cancer recurrence than patients who do not start TNFi treatment, according to an article published online August 8 in the Annals of Rheumatic Disease. "Breast cancer is perhaps the most significant malignancy in RA, since both diseases primarily affect women of older ages," first author Pauline Raaschou, MD, told Medscape Medical News. "Our findings are reassuring for both patients and clinicians, in the sense that they support the use of TNFi in patients with a history of breast cancer which is not particularly aggressive or very recent." Dr. Raaschou, from the Clinical Epidemiology Unit at Karolinska Institutet, Stockholm, Sweden, and colleagues in the Anti-Rheumatic Therapy in Sweden Study Group used linked population-based databases to identify patients with RA with a history of breast cancer. They identified 143 female patients with a history of breast cancer who received TNFi treatment between 1999 and 2010 and matched them with patients selected from a cohort of patients with RA and a history of breast cancer who had not started TNFi treatment (n = 1598). They included 120 TNFi-treated and 120 biologics-naive individuals in their final analysis. For the TNFi patients, who had more severe RA, the median time to...

It’s Not Genes: People Are Fat Because They Eat Too Much

Friday, May 30, 2014

0 Comments

May 27, 2014 "Hi. I am Art Caplan, from the Division of Medical Ethics at the New York University Langone Medical Center in New York. Why are your patients fat? Why are people fat generally? Struggling with weight is a problem. I personally have done better with it lately, but it is a challenge. We all know we are in the middle of an obesity epidemic in the United States. Indeed, worldwide obesity is an increasing problem. If you look at the medical literature, the answer is clear. The problem is in our genes. Again and again, in media reports and in articles that catch the attention of editors at the most prominent medical journals, the answer to why we are all fat is that we have bad genes. Think about it. You go to a cocktail party. You are chatting with people and you start talking about weight. The person says, "I'm one of those high metabolizers (or low metabolizers)," hinting that there is a genetic or biological basis for their size. Or people will say to me, "I must have inherited bad genes. I just can't seem to keep weight off." We love the genetic explanation. That is why it was so interesting to see a paper recently in the British Medical Journal [1] that looked in a very different, but I believe a more fertile, direction for understanding the obesity problem."

Green Tea’s Impact on Cognitive Function Now Clear

Thursday, April 17, 2014

0 Comments

April 16, 2014 Green tea appears to boost memory by enhancing functional brain connectivity, a new imaging study suggests. A study led by Stefan Borgwardt, MD, PhD, from the Department of Psychiatry, University of Basel, Switzerland, shows that drinking a green tea extract enhances memory performance, a finding that researchers suggest may have important clinical implications for the treatment of neuropsychiatric disorders, including cognitive impairment. This is "the first evidence for the putative beneficial effect of green tea on cognitive functioning, in particular, on working memory processing at the neural system level by suggesting changes in short-term plasticity of parieto-frontal brain connections," the investigators write. The study was published online March 19 in Psychopharmacology.